We previously demonstrated that high tumor expression of COX4-1 correlates in a significant manner with worse patient prognosis, whereas high COX4-2 expression does not, suggesting that COX4-1 may have a novel function that differs from that of COX4-2 [15]. This evidence concerns the gene COX4I2 and neoplasm.